IMLINIR

Details for Australian Trade Mark No. 1504515 (hide)

Owner Celgene Corporation

Convention US, 2 May 2012

Service Refer to WIPO Address for Correspondence

Various Convention priority claimed: 2 May 2012, United States of America, No. 85614263 in respect of PHARMACEUTICAL PREPARATIONS, NAMELY, CYTOKINE INHIBITORY DRUGS; PHARMACEUTICAL PREPARATIONS THAT MODULATE THE IMMUNE SYSTEM; PHARMACEUTICAL PREPARATIONS FOR THE

Filing Date 10 May 2012

Classes

Class 5 Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancers and blood diseases and printed dosage instructional manuals sold together as a unit

Event Publications

2 August 2012 Application filed

9 August 2012 Application Accepted

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1504516-E4

1504514-CHUNG JUNG ONE HONGCHO